Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008
Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001
123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992
Determination of Brain Death
NEJM 385:2554-2561, Greer, D.M., 2021
Predictors of Hemorrhagic Transform Occurring Spont & On Anticoagulants in Pts with Acute Ischemic Stroke
Stroke 28:1198-1202, Alexandrov,A.V.,et al, 1997
Early Reperfusion in the'Spectacular Shrinking Deficit'Demonstr by SPECT
Neurol 45:1335-1339, Baird,A.E.,et al, 1995